Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant treatment for pancreatic cancer--a review.
Tse RV, Dawson LA, Wei A, Moore M. Tse RV, et al. Among authors: moore m. Crit Rev Oncol Hematol. 2008 Mar;65(3):263-74. doi: 10.1016/j.critrevonc.2007.08.002. Epub 2007 Dec 11. Crit Rev Oncol Hematol. 2008. PMID: 18063378 Review.
A review of erlotinib and its clinical use.
Tang PA, Tsao MS, Moore MJ. Tang PA, et al. Expert Opin Pharmacother. 2006 Feb;7(2):177-93. doi: 10.1517/14656566.7.2.177. Expert Opin Pharmacother. 2006. PMID: 16433583 Review.
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Brade A, Brierley J, Oza A, Gallinger S, Cummings B, Maclean M, Pond GR, Hedley D, Wong S, Townsley C, Brezden-Masley C, Moore M. Brade A, et al. Among authors: moore m. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1027-36. doi: 10.1016/j.ijrobp.2006.10.015. Epub 2006 Dec 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17197132 Clinical Trial.
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W; National Cancer Institute of Canada Clinical Trials Group. Moore MJ, et al. J Clin Oncol. 2007 May 20;25(15):1960-6. doi: 10.1200/JCO.2006.07.9525. Epub 2007 Apr 23. J Clin Oncol. 2007. PMID: 17452677 Corrected and republished. Clinical Trial.
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process.
Dixon E, Armstrong C, Maddern G, Sutherland F, Hemming A, Wei A, Sherman M, Moore M, McKay A, Urbach D, Labrie M, Gordon L, Barkun J, Lynn Quan M, Dowden S, Bigam D, Gallinger S. Dixon E, et al. Among authors: moore m. J Surg Res. 2009 Sep;156(1):32-38.e1. doi: 10.1016/j.jss.2009.03.084. Epub 2009 May 12. J Surg Res. 2009. PMID: 19592015
7,351 results